253 results on '"Poglajen G"'
Search Results
2. CD 34+ Cell Therapy is Associated with Improved Myocardial Perfusion in Heart Failure with Preserved Ejection Fraction
3. Safety and Efficacy of Semaglutide Therapy in Advanced Heart Failure Patients Awaiting Heart Transplantation
4. LVAD/Stem Cell Combination Therapy in Nonischemic Dilated Cardiomyopathy Patients: Proof-of-Concept Study
5. Prevalence of sustained atrial arrythmias and treatment with zero fluoroscopy or near zero fluoroscopy catheter ablation in Slovenian orthotopic heart transplant recipients
6. (448) Coronary Allograft Vasculopathy is Associated with Decreased Cd34+ Peripheral Cell Count and Increased Vegf Serum Levels
7. (757) Prolonged-Release Tacrolimus-Based Immunosuppression in Heart Transplant Recipients: 5-Year Follow-Up
8. (817) Lvad-Stem Cell Combination Therapy in Non-Ischemic Dilated Cardiomyopathy Patient: Case Report
9. (651) Long-Term Safety and Efficacy of Mrna Sars-Cov2 Vaccination in Heart Transplant Recipients
10. Prognostic Significance of Early Leukopenia in Heart Transplant Recipients
11. Outcomes of COVID-19 in Heart Transplant Recipients
12. Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
13. (470) - LVAD/Stem Cell Combination Therapy in Nonischemic Dilated Cardiomyopathy Patients: Proof-of-Concept Study
14. (373) - Right Ventricular Dysfunction Correlates with Decreased Endothelial Progenitor Cell Mobilisation and Impaired Angiogenesis in HFpEF Patients
15. Impact of atrial fibrillation on outcome in takotsubo syndrome: Data from the international Takotsubo registry
16. Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry
17. Prolonged Release Tacrolimus Has Comparable Safety and Efficacy Profile as Standard Release Tacrolimus in Heart Transplant Recipients
18. Myocardial Scar Burden Correlates with NT-proBNP Levels and Changes in Left Ventricular Filling Pressures in Heart Transplant Recipients
19. Papillary Muscle Viability Correlates with Changes of Functional Mitral Regurgitation in Patients with Nonischemic Dilated Cardiomyopathy
20. Clinical Effects of CD34+ Cell Therapy in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation
21. Stratification of Arrhythmic Risk Using Remote Patient Monitoring in a Heart Transplant Recipient with Coronary Allograft Vasculopathy
22. Myocardial Ischemia Correlates with Right Ventricular Dysfunction in Patients with Noncompaction Cardiomyopathy
23. Coronary Allograft Vasculopathy is Associated with Decreased CD34+ Cell Count in Heart Transplant Recipients
24. Non-Pulsatile Flow is Associated with Lower Levels of Circulating CD34+ Cells in LVAD-Supported Patients
25. Vitamin D Serum Levels are Not Associated with Risk of Skin Cancer in Heart Transplant Recipients
26. CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Patients
27. (539) Decreased Peripheral Cd34+ Cell Count is Associated with Worse Left Ventricular Function in Patients with Takotsubo Cardiomyopathy
28. Clinical Effects of CD34+ Cell Therapy in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation
29. Prolonged Release Tacrolimus Has Comparable Safety and Efficacy Profile as Standard Release Tacrolimus in Heart Transplant Recipients
30. Non-Pulsatile Flow is Associated with Lower Levels of Circulating CD34+ Cells in LVAD-Supported Patients
31. Right Ventricular Function Correlates with Local Mechanical Dyssynchrony of Interventricular Septum in Patients with Non-Ischemic Dilated Cardiomyopathy
32. Myocardial Ischemia Correlates with Right Ventricular Dysfunction in Patients with Noncompaction Cardiomyopathy
33. Papillary Muscle Viability Correlates with Changes of Functional Mitral Regurgitation in Patients with Non-Ischemic Dilated Cardiomyopathy
34. (279) - CD 34+ Cell Therapy is Associated with Improved Myocardial Perfusion in Heart Failure with Preserved Ejection Fraction.
35. Age-Related Variations in Takotsubo Syndrome
36. The Combination of Left Ventricular Assist Device and Laparoscopic Sleeve Gastrectomy May Promote Myocardial Recovery in Obese Advanced Chronic Heart Failure Patients
37. The Impact of Biomarkers in Predicting the Response to CD34+ Cell Therapy in Non-Ischemic Dilated Cardiomyopathy Patients
38. Cell Therapy is Associated with Reduction of Functional Mitral Regurgitation in Cardiomyopathy Patients with High End-Diastolic Volumes
39. Right Ventricular Dysfunction Correlates with Decreased Endothelial Progenitor Cell Mobilisation and Impaired Angiogenesis in Patients with Dilated Cardiomyopathy
40. Short-Term Outcome after Heart Transplantation is Comparable When Using Extended-Criteria Donors
41. Quantiferon-CMV Guided Virostatic Prophylaxis after Heart Transplantation
42. Comparison of Long-Term Effects of Cell Therapy in Patients with Ischemic and. Nonischemic Heart Failure
43. Preemptive Tuberculosis Prophylaxis vs. Watchful Waiting After Heart Transplantation
44. Endocrine Profile of Heart Transplant Recipients in an Early Post-transplant Period
45. Transendocardial Injection of CD34 + Cells Targeting Interventricular Septum Improves Right Ventricular Function in Non-ischemic Dilated Cardiomyopathy
46. Elevated Red Cell Distribution Width is Associated with Increased Incidence of Late Allograft Rejection after Heart Transplantation
47. Safety and Efficacy of Extended Release Tacrolimus After Heart Transplantation
48. (1084) - Safety and Efficacy of Semaglutide Therapy in Advanced Heart Failure Patients Awaiting Heart Transplantation.
49. The Effects of CD34+ Cell Therapy in Heart Failure with Preserved Ejection Fraction
50. Clinical Usefulness of Cardiac Magnetic Resonance Imaging After Heart Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.